Počet záznamov: 1
etanercept
SYS d000068800 LBL 00000nz--a2200181n--4500 005 20250606221739.3 008 160101|||anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D12.644.541.500.697.624 065 $a D12.776.124.486.485.538.500.624 065 $a D12.776.124.486.485.680.697.624 065 $a D12.776.124.790.651.538.500.624 065 $a D12.776.124.790.651.680.660.624 065 $a D12.776.377.715.548.538.500.624 065 $a D12.776.377.715.548.680.660.624 065 $a D12.776.543.750.705.852.760.232 066 $a 01 $c 03 150 $a etanercept $x AA $x AD $x AE $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a proteín fúzny TNFR-Fc $2 slo 450 $w v $a TNTR-Fc $2 slo 550 $7 sllk_us_auth*d000894 $Y Anti-Inflammatory Agents, Non-Steroidal $w P $a antiflogistiká nesteroidné 550 $7 sllk_us_auth*d005765 $Y Gastrointestinal Agents $w P $a látky gastrointestinálne 550 $7 sllk_us_auth*d007166 $Y Immunosuppressive Agents $w P $a imunosupresíva 550 $7 sllk_us_auth*d018501 $Y Antirheumatic Agents $w P $a antireumatiká 665 $a 2016 (1997) $2 eng 680 9-
$i A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS. $2 eng 750 -2
$a Etanercept $2 eng 980 $x M
Počet záznamov: 1